- Home
- PHK vs BBNX Comparison
PHK vs BBNX Comparison
Compare PHK & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHK
- BBNX
- Stock Information
- Founded
- PHK 2003
- BBNX 2015
- Country
- PHK United States
- BBNX United States
- Employees
- PHK N/A
- BBNX N/A
- Industry
- PHK Finance/Investors Services
- BBNX Medical/Dental Instruments
- Sector
- PHK Finance
- BBNX Health Care
- Exchange
- PHK Nasdaq
- BBNX Nasdaq
- Market Cap
- PHK 842.0M
- BBNX 740.7M
- IPO Year
- PHK N/A
- BBNX 2025
- Fundamental
- Price
- PHK $5.00
- BBNX $20.20
- Analyst Decision
- PHK
- BBNX Strong Buy
- Analyst Count
- PHK 0
- BBNX 10
- Target Price
- PHK N/A
- BBNX $24.40
- AVG Volume (30 Days)
- PHK 491.5K
- BBNX 569.5K
- Earning Date
- PHK 01-01-0001
- BBNX 07-29-2025
- Dividend Yield
- PHK 12.61%
- BBNX N/A
- EPS Growth
- PHK N/A
- BBNX N/A
- EPS
- PHK N/A
- BBNX N/A
- Revenue
- PHK N/A
- BBNX $69,830,000.00
- Revenue This Year
- PHK N/A
- BBNX $42.80
- Revenue Next Year
- PHK N/A
- BBNX $34.58
- P/E Ratio
- PHK N/A
- BBNX N/A
- Revenue Growth
- PHK N/A
- BBNX 38911.17
- 52 Week Low
- PHK $4.13
- BBNX $8.89
- 52 Week High
- PHK $5.15
- BBNX $24.50
- Technical
- Relative Strength Index (RSI)
- PHK 71.20
- BBNX N/A
- Support Level
- PHK $4.93
- BBNX N/A
- Resistance Level
- PHK $4.94
- BBNX N/A
- Average True Range (ATR)
- PHK 0.03
- BBNX 0.00
- MACD
- PHK 0.01
- BBNX 0.00
- Stochastic Oscillator
- PHK 96.43
- BBNX 0.00
About PHK Pimco High Income Fund
PIMCO High Income Fund is a closed-end management investment company. The company's primary investment objective is to seek high current income. Its secondary objective is to seek capital appreciation.
About BBNX Beta Bionics Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.